Bottom line
How much do IDNA and LOGSX overlap?
18% of their top holdings overlap by weight. 5 securities appear in both funds' top 25, making up 20.0% of IDNA's assets and 19.1% of LOGSX's. They are substantially different portfolios, so owning both adds real diversification.
IDNA holds far more positions (61 vs 28), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IDNA and LOGSX have in common
| Holding | % of IDNA | % of LOGSX | Overlap |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4.35% | 4.43% | 4.35% |
| Incyte Corporation | 4.23% | 3.30% | 3.30% |
| Merck & Co., Inc. | 3.91% | 3.16% | 3.16% |
| Vertex Pharmaceuticals Incorporated | 3.87% | 3.26% | 3.26% |
| Exelixis, Inc. | 3.65% | 4.95% | 3.65% |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IDNA
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 10.39%
- Bayer Aktiengesellschaft — 4.81%
- Twist Bioscience Corp — 4.79%
- Revolution Medicines, Inc. — 4.55%
- Genmab A/s — 4.23%
- Moderna, Inc. — 4.19%
- Takeda Pharmaceutical Company Limited — 4.05%
- Roche Holding AG — 3.85%
- Ipsen Sa — 3.84%
- BioNTech SE — 3.73%
- Gsk Plc — 3.63%
- Sanofi Sa — 3.46%
- IDEAYA Biosciences Inc — 3.36%
- Immunitybio Inc — 3.07%
- Arcus Biosciences, Inc. — 2.68%
Only in LOGSX
- N/a — 6.91%
- Cardinal Health Inc — 5.86%
- Jazz Pharmaceuticals Plc — 5.77%
- United Therapeutics Corp — 5.11%
- Amgen Inc — 4.86%
- Lantheus Holdings Inc — 4.68%
- Novartis Ag — 4.67%
- Mckesson Corp — 4.53%
- Cencora Inc — 4.46%
- Bristol-myers Squibb Company — 4.02%
- National Healthcare Corp — 3.87%
- Johnson & Johnson — 3.77%
- Medpace Holdings Inc — 3.69%
- Gilead Sciences Inc — 3.50%
- Cigna Group (the) — 3.46%
Asset mix
| Asset type | IDNA | LOGSX |
|---|---|---|
| Stocks | 96.0% | 97.2% |
| Cash & short-term funds | 10.5% | 1.6% |
| Repurchase agreements | — | 6.9% |
| Other | 3.8% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Country mix
| Country | IDNA | LOGSX |
|---|---|---|
| US | 70.2% | 89.7% |
| IE | — | 8.8% |
| DE | 8.5% | — |
| FR | 7.8% | — |
| JP | 6.0% | — |
| CH | 5.4% | 4.7% |
| DK | 4.2% | 2.5% |
| GB | 3.7% | — |
Source: SEC Form N-PORT (periods Jul 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do IDNA and LOGSX overlap?
What stocks do IDNA and LOGSX have in common?
Should I own both IDNA and LOGSX?
Which holds more stocks, IDNA or LOGSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.